Skip to content

France: Extension of framework agreement between French Pharmaceutical Companies Association and Economic Committee for Health Products

05 August 2020

At the end of the Conventional Policy Steering Committee held on 23 July 2020, the French Pharmaceutical Companies Association (Leem) and the French Economic Committee for Health Products (CEPS) agreed to an extension of their Framework Agreement, which is the reference framework for fixing and regulating medicines pricing in France.

The agreement, which would have otherwise expired on 31 July 2020, is now valid until 31 December 2020.

This post was originally co-authored by Jeanne Fabre & Eveline Van Keymeulen.
A prior version of this post was originally published by the same authors in Practical Law – Life Sciences, August 2020 Issue (Thomson Reuters).